GE HealthCare stock gains as Needham sets a USD 93 target

Published on 09/23/2026 at 15:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GE HealthCare stock traded at USD 64.81 on September 22, 2026, after Needham set a USD 93 target. Second-quarter revenue rose 5.7 percent.

Techniker bedient MRT-Scanner in hellem Krankenhaus-Untersuchungsraum mit Flurblick — GE HealthCare US36266G1076 zeigt einen modernen MRT-Scanner im hellen klinischen Krankenhaus mit Techniker, Illustration mit AI erstellt.

GE HealthCare Technologies Inc. (US36266G1076) traded at USD 64.81 on Nasdaq on September 22, 2026, up 1.06 percent from the prior close. The move followed Needham's initiation of coverage with a USD 93 price target, while second-quarter revenue reached USD 5.295 billion.

Needham sees 43.5 percent upside

As Ad-hoc-News reported on September 22, 2026, Needham initiated coverage with a USD 93 target. Compared with the September 22 quote of USD 64.81, the target was USD 28.19 higher, implying 43.5 percent upside from the cited reference price.

The stock's market backdrop remains mixed. Nasdaq data cited in the same September 22 report showed a 52-week range of USD 58.75 to USD 89.77, market capitalization of USD 29.27 billion and volume of 3,471,034 shares. The 2026 performance was still negative at 20.98 percent on that date.

Orders outpace reported revenue

For the quarter ended June 30, 2026, GE HealthCare reported revenue of USD 5.295 billion, up 5.7 percent year over year, according to Securities.io on September 22, 2026. Organic revenue growth was 3.5 percent, while organic orders increased 11.1 percent and backlog reached USD 23.9 billion.

Adjusted EPS was USD 1.13 in the second quarter of 2026, compared with the USD 1.04 consensus cited in the September 22 report, a USD 0.09 beat. The comparison matters because order growth exceeded revenue growth by 7.6 percentage points, pointing to stronger demand entering the order book than the reported sales increase alone would suggest.

Dividend rises to 4 cents

GE HealthCare declared a third-quarter 2026 cash dividend of USD 0.04 per share on September 22, 2026, an increase of 14 percent from the previous quarter, according to TipRanks. The company also reaffirmed its full-year 2026 guidance for organic revenue growth of 3.0 percent to 4.0 percent, adjusted EBIT margin of 15.4 percent to 15.7 percent and adjusted EPS of USD 4.80 to USD 5.00.

Stock remains below yearly high

GE HealthCare stock closed at USD 64.81 on Nasdaq on September 22, 2026, with a daily gain of 1.06 percent. The quote remained USD 24.96 below the reported 52-week high of USD 89.77, leaving the Needham target dependent on a material recovery from the current market level.